Researchers are studying Chikungunya arthritis in hopes it will lead to treatments for patients suffering from rheumatoid arthritis, according to WNDU.com.
Here are four points:
1. By studying Chikungunya arthritis, researchers can learn more about the immunological mechanisms driving joint inflammation.
2. Researchers are comparing the white blood cells between Chikungunya patients and rheumatoid arthritis patients.
3. Both conditions lead to morning stiffness primarily affecting the joints in the hands, wrists, feet and ankles.
4. While Chikungunya can be cured, rheumatoid arthritis can only be treated.
More articles on quality & infection control:
Phoenix nonprofit receives $3.6M federal grant for healthcare improvement: 5 notes
Making varsity: Indiana University coaching physicians to improve care with $46M grant
CDC & FDA issues alert to healthcare facilities — 4 notes
